Hdt Bio
WA · 4 filings, 2025
Lobbying spend · 2025
$124K
to shape legislation
About the organization
HGC019 is a mRNA and Self-amplifying mRNA (saRNA) based COVID-19 vaccine candidate being developed by Gennova Biopharmaceuticals and HDT Bio Corp. with active support from NIH under The Indo-US Vaccine Action Program (VAP) and Department of Biotechnology, India. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Medical/Disease Research/Clinical Labs · Science/Technology · Medicare/Medicaid
2Through these firms · 1
THE VOGEL GROUP
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5224A bill to improve training for airport drivers in the movement area at commercial service airports through…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5226A bill to require social media platform providers to obtain parental consent with respect to children creat…